WalneAJJenkinsPJJamesITPlowmanPN. Pyridinium crosslinks in the monitoring of patients with bone metastases from carcinoma of the breast. Clin Oncol1997; 9: 30–4.
2.
SammaSKagebayashiYYasukawaMFukuiYOzonoSHiraoYSequential changes of urinary pyridinoline and deoxypyridinoline as markers of metastatic bone tumor in patients with prostate cancer: A preliminary study. Jpn J Clin Oncol1997; 27: 26–30.
3.
MundyGR. Ectopic production of calciotropic peptides. Endocrinol Metab Clin North Amer1991; 20: 473–87.
4.
LiptonADemersLDaniloffYCurleyEHamiltonCHarveyHIncreased urinary excretion of pyridinium cross-links in cancer patients. Clin Chem1993; 39: 614–8.
5.
PecherstorferMZimmer-RothISchillingTWoitgeHWSchmidtHBaumgartnerGThe diagnostic value of urinary pyridinium crosslinks of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease. J Clin Endocrinol Metab1995; 80: 97–103.
6.
BodyJJDelmasPD. Urinary pyridinium crosslinks as markers of bone resorption in tumor-associated hypercalcaemia. J Clin Endocrinol Metab1992; 74: 471–5.
7.
AbbiatiGArrigoniMFrignaniSLongoniABartucciFCastiglioniC.Effect of salmon calcitonin on deoxypyridinoline (Dpyr) urinary excretion in healthy volunteers. Calcif Tissue Int1994; 55: 346–8.
8.
BudayrAZyssetEJenzerAThiebaudDAmmannPRizzoliREffects of treatment of malignancy-associated hypercalcaemia on serum parathyroid hormone-related protein. J Bone Miner Res1994; 9: 521–6.
9.
KasonoKIsozakiOSatoKSatoYShizumeKOhsumiKEffects of glucocorticoids and calcitonin on parathyroid hormone-related protein (PTHrP) gene expression and PTH-rP release in human cancer cells causing humoral hypercalcemia. Jpn J Cancer Res1991; 82: 1008–14.
10.
WimalawansaSJ. Significance of plasma PTHrp in patients with hypercalcaemia of malignancy treated with biphosphonate. Cancer1994; 73: 2223–30.
